Press Releases

Press Releases

November 13, 2018
Establishment Labs Reports Third-Quarter 2018 Financial Results
NEW YORK, Nov. 13, 2018 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on improving patient safety and aesthetic outcomes, initially in the breast aesthetics and reconstruction market, today announced its financial results for the third
November 5, 2018
Establishment Labs to Present at Jefferies 2018 London Healthcare Conference
NEW YORK, Nov. 05, 2018 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on improving patient safety and aesthetic outcomes, initially in the breast aesthetics and reconstruction market, today announced that Juan José Chacón-Quirós,
November 1, 2018
Establishment Labs to Release Third Quarter 2018 Financial Results on November 13, 2018
NEW YORK, Nov. 01, 2018 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (NASDAQ: ESTA) today announced that the Company will release its third quarter 2018 financial results on Tuesday, November 13, 2018, prior to the open of U.S. financial markets.
October 4, 2018
Establishment Labs Announces Transition to a Direct Sales Force in Germany and Spain During its 4th Annual World Symposium on Ergonomic Implants
NEW YORK, Oct. 04, 2018 (GLOBE NEWSWIRE) -- Establishment Labs Holdings, Inc. (NASDAQ: ESTA), a medical technology company focused on improving patient safety and aesthetic outcomes, initially in the breast aesthetics and reconstruction market, announced today at the Annual World Symposium on
September 4, 2018
Establishment Labs announces transition to a Direct Sales Force in the United Kingdom

NEW YORK, Sept. 04, 2018 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on improving patient safety and aesthetic outcomes, initially in the breast aesthetics and reconstruction market, announced today that it is transitioning, effective

August 14, 2018
Establishment Labs Reports Second Quarter 2018 Financial Results

NEW YORK, Aug. 14, 2018 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on improving patient safety and aesthetic outcomes, initially in the breast aesthetics and reconstruction market, reported financial results for the second quarter ended

August 7, 2018
Establishment Labs to Release Second Quarter 2018 Financial Results on August 14, 2018

NEW YORK, Aug. 07, 2018 (GLOBE NEWSWIRE) -- Establishment Labs (NASDAQ: ESTA) today announced that the Company will release its second quarter 2018 financial results on Tuesday, August 14, 2018, prior to the open of U.S. financial markets. Establishment Labs will host a conference call and webcast

July 23, 2018
Establishment Labs Announces Closing of Initial Public Offering and Exercise in Full of Underwriters' Option to Purchase Additional Common Shares
NEW YORK, July 23, 2018 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (NASDAQ:ESTA), a global medical technology company focused on breast aesthetics and reconstruction technologies, today announced the closing of its initial public offering of 4,272,568 common shares, including the full
July 19, 2018
Establishment Labs Celebrates Initial Public Offering on the Nasdaq Stock Market
NEW YORK, July 19, 2018 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (NASDAQ:ESTA) today announced that the company’s common stock commenced trading on the Nasdaq Stock Market under the trading symbol “ESTA” following its initial public offering.
July 18, 2018
Establishment Labs Announces Pricing of Initial Public Offering
NEW YORK, July 18, 2018 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (NASDAQ:ESTA), a global medical technology company focused on breast aesthetics and reconstruction technologies, today announced the pricing of its initial public offering of 3,715,277 common shares at a public offering
Displaying 1 - 10 of 13